Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Sales: 2018-2025

Historic Return on Sales for Arcus Biosciences (RCUS) over the last 7 years, with Sep 2025 value amounting to -1.80%.

  • Arcus Biosciences' Return on Sales fell 78.00% to -1.80% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.80%, marking a year-over-year decrease of 78.00%. This contributed to the annual value of -1.10% for FY2024, which is 153.00% up from last year.
  • As of Q3 2025, Arcus Biosciences' Return on Sales stood at -1.80%, which was up 34.94% from -2.77% recorded in Q1 2025.
  • Over the past 5 years, Arcus Biosciences' Return on Sales peaked at 0.18% during Q3 2022, and registered a low of -7.35% during Q3 2021.
  • Over the past 3 years, Arcus Biosciences' median Return on Sales value was -2.07% (recorded in 2023), while the average stood at -1.85%.
  • Its Return on Sales has fluctuated over the past 5 years, first slumped by 623bps in 2021, then surged by 754bps in 2022.
  • Quarterly analysis of 5 years shows Arcus Biosciences' Return on Sales stood at 0.14% in 2021, then crashed by 252bps to -2.38% in 2022, then dropped by 24bps to -2.62% in 2023, then soared by 153bps to -1.10% in 2024, then tumbled by 78bps to -1.80% in 2025.
  • Its last three reported values are -1.80% in Q3 2025, -2.77% for Q1 2025, and -1.10% during Q4 2024.